CardioTech Refocuses On Core Polymer Technologies After Gish Divestiture
This article was originally published in The Gray Sheet
Executive Summary
CardioTech International is building its business around its polymer science and engineering expertise, following the recent divestiture of the Gish Biomedical disposable surgical product unit